{
  "ticker": "LLY",
  "target_date": "2025-03-07",
  "actual_date": "2025-03-07",
  "collected_at": "2025-12-08T11:29:31.581346",
  "price": {
    "open": 900.24,
    "high": 902.83,
    "low": 856.49,
    "close": 864.6295776367188,
    "volume": 4818100,
    "change_1d_pct": -4.73,
    "change_7d_pct": -4.96,
    "change_30d_pct": 13.63
  },
  "technicals": {
    "rsi_14": 56.25,
    "sma_20": 882.03,
    "sma_50": 821.76,
    "macd": 23.429,
    "macd_signal": 26.255,
    "macd_histogram": -2.827,
    "bb_upper": 933.51,
    "bb_lower": 830.56,
    "price_vs_sma20_pct": -1.97,
    "price_vs_sma50_pct": 5.22,
    "volume_ratio": 1.4
  },
  "fundamentals": {
    "market_cap": 891302117376,
    "pe_ratio": 48.713867,
    "forward_pe": 43.876877,
    "price_to_book": 37.434113,
    "price_to_sales": 15.000086,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.59,
    "pct_from_52w_low": 59.39
  },
  "macro": {
    "spy": {
      "price": 570.92,
      "change_1d_pct": 0.56,
      "change_7d_pct": -1.56
    },
    "vix": {
      "level": 23.37,
      "signal": "ELEVATED"
    },
    "treasury_10y": {
      "yield_pct": 4.32
    },
    "dollar_index": {
      "level": 103.84
    },
    "gold": {
      "price": 2904.7
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Hims & Hers to shut down dermatology business Apostrophe",
      "source": "Finnhub",
      "datetime": 1741371801,
      "summary": "Hims & Hers Health would discontinue Apostrophe, its personalized acne treatments dermatology business, the company said on Friday. Apostrophe is being shut down to simplify its ...",
      "url": "https://finnhub.io/api/news?id=cf6ed5ff1c9bc055acd29c23c90e09ed5f30917b73838ee55f49bd4c4f50e141"
    },
    {
      "headline": "Eli Lilly CEO's Total Compensation Rose 10% in 2024",
      "source": "Finnhub",
      "datetime": 1741368667,
      "summary": "By Connor Hart Eli Lilly Chief Executive David Ricks annual compensation rose to $29.2 million in 2024, a 10% increase from the $26.2 million he received a year earlier. Ricks' payout included...",
      "url": "https://finnhub.io/api/news?id=7fc040f6a37094e8331fb719d60c96b241481966694181844151c1802bb255eb"
    },
    {
      "headline": "Eli Lilly & Co. stock underperforms Friday when compared to competitors",
      "source": "MarketWatch",
      "datetime": 1741365060,
      "summary": "Eli Lilly & Co. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=1669bd450fce007c6c646aa587ef3cdd44897faa6e1013d3c65397ce46c2c2cb"
    },
    {
      "headline": "US judge denies injunction, restricting copies of Lilly weight-loss drug",
      "source": "Finnhub",
      "datetime": 1741350527,
      "summary": "A U.S. federal judge has refused to allow compounding pharmacies to keep making copies of Eli Lilly's popular weight-loss and diabetes drugs Zepbound and Mounjaro in the United States. ...",
      "url": "https://finnhub.io/api/news?id=cc553cff2f207a117c2cbf42af4f3dd38c9cc7d1bf37a418d5038dfdce4ddf0c"
    },
    {
      "headline": "Pfizer Vs. Johnson & Johnson: Who's The Better Bargain For Investors",
      "source": "SeekingAlpha",
      "datetime": 1741340054,
      "summary": "Discover the strengths & weaknesses of healthcare giants Johnson & Johnson and Pfizer. Find out which stock is more promising for long-term investors.",
      "url": "https://finnhub.io/api/news?id=a2dd56b014439c476c94b99818c078982b06255bce3559661474d82856504139"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-03-04",
      "description": "xslF345X05/form4-03042025_040301.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000141588925006450/xslF345X05/form4-03042025_040301.xml"
    },
    {
      "form": "4",
      "date": "2025-03-03",
      "description": "xslF345X05/wk-form4_1741038785.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000083/xslF345X05/wk-form4_1741038785.xml"
    },
    {
      "form": "4",
      "date": "2025-03-03",
      "description": "xslF345X05/wk-form4_1741038712.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000081/xslF345X05/wk-form4_1741038712.xml"
    },
    {
      "form": "4",
      "date": "2025-02-26",
      "description": "xslF345X05/form4-02262025_040201.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000141588925005670/xslF345X05/form4-02262025_040201.xml"
    },
    {
      "form": "4",
      "date": "2025-02-25",
      "description": "xslF345X05/form4-02252025_040201.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000141588925005456/xslF345X05/form4-02252025_040201.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}